Repository logo
 

Assessment of vitamin E status in patients with systemic inflammatory response syndrome: Plasma, plasma corrected for lipids or red blood cell measurements?

dc.contributor.authorVasilaki, Katerinaen
dc.contributor.authorLeivaditi, Dimitraen
dc.contributor.authorTalwar, Dineshen
dc.contributor.authorKinsella, Johnen
dc.contributor.authorDuncan, Andrewen
dc.contributor.authorO'Reilly, Denis St J.en
dc.contributor.authorMcMillan, Donald C.en
dc.date.accessioned2022-03-30T08:48:44Z
dc.date.available2022-03-30T08:48:44Z
dc.date.issued2009-08-19
dc.descriptionPreviously deposited in University of Glasgow repository on 14 October 2009 at: http://eprints.gla.ac.uk/7696/en
dc.descriptionItem not available in this repository.
dc.descriptionKaterina Vasilaki – ORCID: 0000-0003-2669-5691 https://orcid.org/0000-0003-2669-5691
dc.description.abstractBackground: There is some evidence that the plasma vitamin E status is perturbed as part of systemic inflammatory response and correcting this with other plasma markers may not lead to reliable results. The aim of the present study was to examine the longitudinal inter-relationships between plasma and red blood cell vitamin α-tocopherol in patients with systemic inflammatory response syndrome. Methods: α-tocopherol concentrations were measured, by HPLC, in plasma and red blood cells in normal subjects (n = 67) and in critically ill patients with systemic inflammatory response syndrome (n = 82) on admission and on follow-up. Results: Plasma α-tocopherol was significantly lower in the critically ill patients compared with the controls (all p < 0.001) with 41% of patients having concentrations below the 95% confidence interval. In contrast, when corrected for cholesterol, α-tocopherol concentrations were significantly higher in the critically ill patients compared with the control group (p < 0.001, 27% above the 95% confidence interval) and when corrected for triglycerides, α-tocopherol concentrations were significantly lower in the critically ill patients compared with the control group (p < 0.001). Red blood cell α-tocopherol corrected for haemoglobin was similar (p = 0.852) in the critically ill patients compared with control subjects. The longitudinal measurements (n = 53) gave similar results. Conclusions: These results indicate that there is a discrepancy between vitamin E measurements in plasma, in plasma corrected for lipids and in red blood cells. Although the value of correcting vitamin E concentrations by lipids is well established in population studies, the present study indicates that such correction is unreliable in the presence of systemic inflammatory response syndrome and that vitamin E status should be assessed using red blood cell α-tocopherol measurement.en
dc.description.ispublishedpub
dc.description.number1-2en
dc.description.sponsorshipDT, JK, AD, D O'R and DMCM conceived the idea of examining the relationship of α-tocopherol concentrations in plasma and red blood cells in patients with critical illness and funded the study.en
dc.description.statuspub
dc.description.urihttps://doi.org/10.1016/j.cca.2009.08.008en
dc.description.volume409en
dc.format.extent41-45en
dc.identifier.citationVasilaki, K., Leivaditi, D., Talwar, D., Kinsella, J., Duncan, A., O'Reilly, D.S.J. and McMillan, D.C. (2009) ‘Assessment of vitamin E status in patients with systemic inflammatory response syndrome: Plasma, plasma corrected for lipids or red blood cell measurements?’, Clinica Chimica Acta, 409(1-2), pp. 41-45.en
dc.identifier.issn0009-8981en
dc.identifier.urihttps://doi.org/10.1016/j.cca.2009.08.008
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/11967
dc.language.isoenen
dc.publisherElsevieren
dc.relation.ispartofClinica Chimica Actaen
dc.subjectVitamin Een
dc.subjectPlasmaen
dc.subjectCholesterolen
dc.subjectTriglyceridesen
dc.subjectRed Blood Cellen
dc.subjectSystemic Inflammatory Responseen
dc.subjectControl Subjectsen
dc.subjectCritically Ill Patientsen
dc.titleAssessment of vitamin E status in patients with systemic inflammatory response syndrome: Plasma, plasma corrected for lipids or red blood cell measurements?en
dc.typeArticleen
dcterms.accessRightsnone
dcterms.dateAccepted2009-08-11
qmu.authorVasilaki, Katerinaen
refterms.accessExceptionNAen
refterms.depositExceptionNAen
refterms.panelUnspecifieden
refterms.technicalExceptionNAen
refterms.versionNAen
rioxxterms.publicationdate2009-08-19
rioxxterms.typeJournal Article/Reviewen

Files